Objective: To investigate determinants (pathophysiologic and physiologic, behavioural and lifestyle) of vitamin D status in Irish Crohn's disease (CD) patients. Design: A cross-sectional observational study. Setting: Cork City, Ireland (521N). Subjects: Crohn's Disease patients (n ¼ 58; mean age 38.1 years) were recruited from Cork University Hospital. Results: Fifty and nineteen percent of Irish CD patients were vitamin D deficient (defined by serum 25 hydroxyvitamin (OH) D levels o50 nmol/l) during winter and summer, respectively. Multiple regression analysis showed that summer-time serum 25 (OH) D levels were positively associated with use of vitamin D supplements (P ¼ 0.033) and negatively associated with smoking (P ¼ 0.006) and being male (P ¼ 0.063). During winter-time, use of vitamin D supplements (P ¼ 0.041) and sun habits (P ¼ 0.066) were positively associated, whereas small intestinal involvement (P ¼ 0.005) and body mass index (BMI) (P ¼ 0.083) were negatively associated with serum 25 (OH) D levels. There was no significant association between other nonpathophysiologic (age, dietary calcium or vitamin D) or pathophysiologic factors (steroid use, resection), and serum 25 (OH) D levels, at either season. Approximately 41 and 60% of the total variation in summer-and winter-time serum 25 (OH) D, respectively, was explained by this model. Conclusion: A high proportion of Irish CD patents had some level of vitamin D deficiency (o50 nmol/l) during late-wintertime. Use of regular low-dose supplemental vitamin D, particularly by patients with small intestinal involvement, cessation of smoking and adequate, but responsible, exposure to summer sunlight as well as maintaining BMI in the normal range could help maintain adequate vitamin D levels during wintertime.
Introduction
Poor vitamin D status is common in healthy Irish adults as well as in adults from several other European countries, especially during winter-time (Doyle et al., 2005; Hill et al., 2005a , for a review, see Ovesen et al., 2003) . Vitamin D deficiency/insufficiency is also common in patients with Crohn's disease (CD) (Driscoll et al., 1982; Harries et al., 1985; Haderslev et al., 2003) , with some suggesting it as one of the commonest nutritional complications in CD patients (Tajika et al., 2004) . Although the prevalence of vitamin D insufficiency peaks during winter-time (with reported low serum 25-hydroxyvitamin D (25 (OH) D) in 30-68% of patients; Driscoll et al., 1982; Harries et al., 1985; Jahnsen et al., 2002) , even during late summer-time, serum 25 (OH) D has been shown to be lower in CD patients than age-and sex-matched healthy control subjects in Ireland (McCarthy et al., 2005) as well as elsewhere in Europe (Harries et al., 1985; Andreassen et al., 1998) .
A reduced efficiency of intestinal absorption of vitamin D, as a consequence of ileopathy (Haderslev et al., 2003) , a disrupted enterohepatic circulation of vitamin D (Arnaud et al., 1975) and/or renal insufficiency (Freaney et al., 1993) have been suggested as possible contributory factors to the lower vitamin D status in CD patients. Disease activity (Harries et al., 1985; Tajika et al., 2004) has also been suggested to influence vitamin D status in CD. However, in addition to these pathophysiologic factors, other physiological and behavioural factors, which have been shown to be determinants of serum 25 (OH) D levels in healthy adults, may also influence vitamin D status in CD patients. These include age, gender, race, body mass index (BMI), smoking, sunshine habits, Ca intake and vitamin D supplementation (Holick, 1995; Hill et al., 2005b) . No previous study has considered the relative importance of pathophysiologic and nonpathophysiologic factors as determinants of vitamin D status in CD patients and how their relative importance may be modulated by season. Knowledge of these determinants of vitamin D status is of importance for the development of strategies for prevention of sub-optimal vitamin D status in CD patients.
Therefore, the objective of the present study was to investigate determinants of serum 25 (OH) D levels in Irish CD patients, including their relative importance during summer-and winter-time.
Subjects and methods

Subjects
Patients attending the Cork University Hospital IBD Clinic were sent a research information bulletin which provided information about the present study. Consecutive patients, in whom there was a confirmed diagnosis of CD, were included from those who volunteered for the study after receiving the research information bulletin. No patient refused entry to the study after being interviewed and informed of the requirements and details. Crohn's disease was previously diagnosed on the basis of consistent clinical findings, barium radiology and histology. A total of 58 CD patients (23 males, 35 females) were included in the study in September-October, 2002. Mean age, weight, height, BMI, disease duration and the ratio of males to females for the patient population at baseline are provided in Table 1 . Of the 58 CD patients who presented at the first visit, 50 patients (21 males, 29 females) returned for a second visit in March, 2003 . Of these patients, 10 and 12 patients were in the active phase of disease during the first and second visit, respectively. Forty-eight and thirty-eight patients were in clinical remission during the first and second visit, respectively. Remission was defined at the time of study as the absence of gastrointestinal symptoms and not requiring therapeutic doses of corticosteroids.
For CD patients in remission at baseline, the mean length of remission was 27 months (range 2-84 months). The mean erythrocyte sedimentation rate was 9 (2-21/h) and only two patients had modestly elevated C-reactive protein concentration of 28 (normal o10 mg/l). The mean serum albumin concentration was 37 g/l with only two patients having a low level (25 and 28 g/l). All patients were on 5-aminosalicylates (2-3 g/day) maintenance, eight were taking 6-mercaptopurine (50 mg/day) or azathioprine (100 mg/day). None had received infliximab or other anti-tumour necrosis factor therapy. Patients with active disease received oral steroids (commencing with oral prednisolone 40 mg/day and tapering over 12 weeks).
Ten of the patients had small bowel involvement only, eight patients had inflammation of the colon and 40 had inflammation in both sites. Thirty-three patients had a previous terminal ileal resection (o50 cm) and none had ever had steatorrhea or short bowel syndrome.
Six female patients were postmenopausal; of those three patients were receiving hormone replacement therapy (HRT). Seven female CD patients were taking oral contraceptive medications. None of the patients were taking activated forms of vitamin D (25 OH D or 1,25 (OH) 2 D), PTH, parathyroid hormone, calcitonin, anticonvulsants or bisphosphonates, whereas seven patients were regular cigarette smokers.
At the first visit, 21 patients (B36%) were taking vitamin D-containing supplements (in the range 2.5-20 mg/day), Collection and preparation of samples Blood was collected by venepuncture into a vacutainer tube with no additive and processed to serum, which was immediately stored at À801C until required for analysis.
Experimental techniques
Serum 25-hydroxyvitamin D. Serum 25-hydroxyvitamin D (25 (OH) D) levels were measured in serum samples using a recently developed ELISA (OCTEIA s 25-Hydroxy Vitamin D, Immuno Diagnostic Systems, Ltd, Boldon, UK). The intraand inter-assay CV was 5.9 and 6.6%, respectively. The quality and accuracy of our serum 25 (OH) D analysis is assured on an ongoing basis by participation in the Vitamin D External Quality Assessment Scheme (Charing Cross Hospital, London, UK). There is no international consensus on cutoff levels for vitamin D deficiency and vitamin D insufficiency (McKenna, 1992; Zittermann, 2003) . Therefore, for illustrative and comparative purposes in the present study, two suggested sets of serum 25 (OH) D cutoff values for defining vitamin D status were used. These include the definitions of vitamin D status suggested by Heaney and Weaver (2003) (o80 nmol/l, insufficient; 480 nmol/l sufficient) and Lips (2004) (450 nmol/l, replete; 25-50 nmol/l, mildly deficient; 12.5-25 nmol/l; moderately deficient; o12.5 nmol/l, severely deficient).
Statistical analysis
Data are presented as means and standard deviations. Data for all variables were normally distributed and allowed for parametric tests of significance. Differences in serum 25 (OH) D between patients with active disease and those in clinical remission were analysed using unpaired Student's t-tests. A between-season comparison of serum 25 (OH) D was made by paired Student's t-tests. Differences in serum 25 (OH) D as well as in physical variables between vitamin D supplement users and non-users were analysed using unpaired Student's t-tests. Multiple regression analysis was performed to identify independent predictors of serum 25 (OH) D. The following categorical variables were included: gender (male or female), vitamin D supplements (coded as: 0 ¼ no supplements, 1 ¼ taking supplements regularly), sun habits ('do you prefer to: avoid sun during summer season (avoid sun) or stay in sun during the summer season (prefer sun)'), sun holidays within the previous 3 months (coded as: 0 ¼ no, 1 ¼ yes), sunscreen use (sun protection factor 8 and above) (coded as: 0 ¼ no, 1 ¼ yes), current oral steroid use (coded as: 0 ¼ no, 1 ¼ yes), small bowel involvement (coded as: 0 ¼ no, 1 ¼ yes), intestinal resection (coded as: 0 ¼ no, 1 ¼ yes), smoking habits ('are you a current smoker or non-smoker'). The following continuous numerical variables were included: age (years), BMI (kg/m 2 ), vitamin D intake (mg/day) and calcium intake (mg/day). P-values o0.05 were considered statistically significant, whereas P-values between 0.05 and 0.10 were considered as trends. The Statistical Package for the Social Sciences (SPSS for Windowst Version 10.0, SPSS Inc., Chicago, IL, USA) was used for statistical analysis.
Results
Physical characteristics
The age, weight, height, BMI and disease duration of the Irish adult CD patients (n ¼ 58) are shown in Table 1 . Stratification of CD patients into users (n ¼ 21) and nonusers (n ¼ 37) of vitamin D-containing supplements showed that there was no significant difference in any of these physical characteristics (Table 1) . (Table 2) .
In a subanalysis of the data, CD patients were stratified into 'users' and 'non-users' of vitamin D-containing supplements (Table 2 ). Crohn's disease patients who took vitamin D supplements during late-winter had significantly higher serum 25 (OH) D concentrations compared to those patients who did not take vitamin D-containing supplements. There was no significant difference in serum 25 (OH) D between vitamin D-containing supplement users or non-users during late-summer (Table 2) .
There was a significant seasonal variation in serum 25 (OH) D concentrations in both users and non-users of vitamin D-containing supplements (Table 2 ). However, there was less of a drop in serum 25 (OH) D concentrations from late-summer to late-winter in the supplement users (10.9 nmol/l) compared to the non-users (22.6 nmol/l) (Po0.05).
Prevalence of vitamin D deficiency/insufficiency and impact of vitamin D supplement use
The prevalence of vitamin D deficiency/insufficiency among CD patients during summer and winter, using serum 25 (OH) D cutoffs levels for defining vitamin D status as suggested by Lips (2004) and Heaney and Weaver (2003) , are shown in Table 3 . Vitamin D supplement use led to a lower frequency of CD patients with vitamin D deficiency/insufficiency, in both seasons (Table 3) .
Determinants of serum 25 (OH) D levels
To investigate the determinants of serum 25 (OH) D levels in adult Irish CD patients multiple regression analysis was performed during summer-time and again during wintertime, and the outcomes are presented in Table 4 . During late-summer, use of vitamin D-containing supplements Determinants of vitamin D status in Crohn's disease patients J Gilman et al (P ¼ 0.039) were positively associated with serum 25 (OH) D levels, whereas smoking (P ¼ 0.008) was negatively associated with serum 25 (OH) D levels (Table 4) . Being male tended (P ¼ 0.063) to be negatively associated with serum 25 (OH) D levels (Table 4 ). There was no significant association between the other non-pathophysiologic factors, or any of the pathophysiologic factors, and serum 25 (OH) D levels (Table 4) . Approximately 41% of the total variation in summer-time serum 25 (OH) D concentration was explained by this model. During late-winter, use of vitamin D-containing supplements (P ¼ 0.041) was positively associated with serum 25 (OH) D levels, whereas small intestinal involvement (P ¼ 0.005) was negatively associated with serum 25 (OH) D levels (Table 4) . Sun habits tended (P ¼ 0.066) to be positively and BMI tended (P ¼ 0.083) to be negatively associated with serum 25 (OH) D levels (Table 4 ). There was no significant association between the other non-pathophysiologic factors, or any of the pathophysiologic factors, and serum 25 (OH) D levels (Table 4) . Approximately 60% of the total variation in winter-time serum 25 (OH) D concentration was explained by this model.
Discussion
In Northern latitudes of 40-601N, including Ireland at 51-551N, sunlight is not of sufficient intensity during the winter months (October-March) to stimulate cutaneous synthesis of vitamin D (Webb et al., 1988 Ovesen et al., 2003) . Patients with CD have even a higher risk of poor vitamin D status for a number of pathophysiologic reasons as well as possibly due to other physiological and behavioural factors.
The mean serum 25 (OH) D levels in Irish adult CD patients were, on average, relatively good. For example, much lower mean serum 25 (OH) D levels and/or higher prevalence of low vitamin D status among adult CD patients have been reported during winter-time compared to that observed in the present study (Driscoll et al., 1982; Harries et al., 1985; Andreassen et al., 1998; Geerling et al., 1998; Scott et al., 2000; Schoon et al., 2001; Jahnsen et al., 2002; Haderslev et al., 2003) . It must be emphasized, however, that vitamin D status is strongly influenced by geographical differences (Ovesen et al., 2003) , making between-country comparisons difficult to interrupt. In comparison to other healthy Irish population subgroups, which had winter-time serum 25 (OH) D levels assessed the same year and by the same analytical technique for serum 25 (OH) D, the CD patients had relatively similar mean serum 25 (OH) D levels compared to those of 50-to 70-year-old women (mean (s.d.): 68.6 (34.9), n ¼ 47; Hill et al., 2005a) and 39-to 64-year-old men (mean (s.d.); 58.8 (22.4), n ¼ 36; Doyle et al., 2005) . However, McCarthy et al. (2005) recently reported that in age-and sex-matched healthy control subjects, Irish CD patients had significantly lower serum 25 (OH) D levels during winter-time and also during summer-time.
The relatively good vitamin D status of these Irish CD patients was, at least in part, due to their dietary intake of the vitamin as well as their use of supplemental vitamin D (taken by 34-44% of the patients, even in summer-time). Daily vitamin D supplement use is recommended for IBD, Inflammatory Bowel Disease patients who are receiving systemic steroids (Scott et al., 2000) . The majority of CD patients in the present study were in remission and not taking steroids; however, they may have continued the practise of taking supplemental vitamin D as a prophylatic measure even after ceasing steroid treatment, which might explain the high proportion of supplement users. Haderslev et al. (2003) reported that of a group of adult patients with small intestinal resection (predominantly CD patients) about 57% were taking oral vitamin D supplementation, even though these patients were in remission.
Although there was a seasonal variation in serum 25 (OH) D levels in CD patients in the present study, irrespective of whether they were taking and not taking vitamin D-containing supplements, the decline in winter-time serum 25 (OH) D levels from the preceding summer was, on average, much less (10.9 nmol/l) in the supplement users compared to that in the supplement non-users (22.6 nmol/l). Thus, supplement use (even with supplements containing 7 mg, on average) was to some degree protective of vitamin D status during winter-time. However, the level of protection offered by vitamin D-containing supplements depends on the serum 25 (OH) D cutoff values of vitamin D adequacy/sufficiency applied; a hotly debated topic at present (Holick, 2004; Lips, 2004) . In the present study, 72% of the CD patients taking (Scott et al., 2000) . In the present study, only three out of the 58 CD patients had an intake of 20 mg/day or more, and none of the three were able to achieve this dietary intake without using supplements. It may be timely to consider whether use of vitamin D supplements, especially during winter, should be a more general recommendation for CD patients rather than reserved for only those patients undergoing steroid treatment.
The importance of vitamin D-containing supplements was again highlighted by the findings from our multiple linear regression analysis which showed that supplemental vitamin D use was positively associated with serum 25 (OH) D levels during winter-time, but also during summer-time. However, a knowledge of other determinants of vitamin D status is also important for formulation of strategies and recommendations for preventing vitamin D deficiency in CD patients. In the present study, age, calcium intake, steroid use, small intestinal resection and dietary vitamin D intake were not associated with serum 25 (OH) D levels in Irish CD patients, irrespective of season, whereas gender and BMI tended to be associated with serum 25 (OH) D levels during one but not the other season. The effect of gender and BMI may have become more statistically significant if the study had larger subject numbers. Gender and BMI have been suggested as determinants of serum 25 (OH) D in healthy adults in some (MacLaughlin and Holick, 1985; Arunabh et al., 2003) , but not all studies (Burnand et al., 1992; van der Wielen et al., 1995; Lamberg-Allardt et al., 2001) . The data are very limited in relation to the influence of gender on serum 25 (OH) D levels in CD patients. Andreassen et al. (1998) found that gender was not a determinant of low vitamin D status in study of 115 adult CD patients. Some studies of CD patients have reported BMI as a determinant of serum 25 (OH) D levels (Harries et al., 1985) , whereas others have failed to find an effect of BMI on vitamin D status (Andreassen et al., 1998; Tajika et al., 2004) .
Dietary factors, such as dietary vitamin D and calcium intake, have also been shown to influence vitamin D status, but in healthy adults (van der Wielen et al., 1995; Jacques et al., 1997; Bates et al., 2003) . A high calcium intake may suppress PTH levels, leading to a decrease in 1,25 (OH) 2 D levels, and thus, have a sparing effect on serum 25 (OH) D (Lips, 1998) . In the present study, the mean total calcium intake in CD patients was 1482 mg and only 14% of patients had calcium intakes less than the RDA, Recommended Dietary Allowance (800 mg/day) (Food Safety Authority of Ireland, 1999) . Vitamin D intake was not associated with winter-time serum 25 (OH) D levels in CD patients in the present study. It should be noted, however, that habitual vitamin D intake was assessed in patients during summertime and we can only assume that there was a lack of seasonal variation in dietary vitamin D intake in these patients, which has been shown for healthy Irish adults (18-50 years) (Hill et al., 2004) . The relationship between vitamin D intake and serum 25 (OH) D levels has been seen in some studies of CD patients (Vogelsang et al., 1995) , but not others (Harries et al., 1985; Sentongo et al., 2002) . The reasons for this are unclear. However, according to Jacques et al. (1997) , vitamin D intake only becomes a significant predictor of serum 25 (OH) D concentration, when intakes are above B4 mg/day. The median vitamin D intake in the present study was only 4.1 mg/day and about two-thirds of patients had intakes below 5 mg/day, which may explain the lack of relationship between vitamin D intake and wintertime vitamin D status.
Of other lifestyle or behavioural factors that could potentially influence vitamin D status in CD patients, smoking was negatively associated with serum 25 (OH) D levels in CD patients, but only during summer-time. The reasons for a negative effect of smoking on serum 25 (OH) D levels at one season and not the other are unclear, but may relate to the better status during summer. Some studies show a negative association between smoking and serum 25 (OH) D in young, middle-aged and elderly healthy subjects (Brot et al., 1999; Lamberg-Allardt et al., 2001; Ilich et al., 2002; Andersen et al., 2005) , whereas others fail to find this association (Scragg et al., 1992; Jacques et al., 1997; Arunabh et al., 2003) . Although the mechanism remains unclear, it is thought that the association between smoking and serum 25 (OH) D level is not likely to be explained by other confounding lifestyle factors (Brot et al., 1999) . Smoking has also been suggested as a risk factor for CD itself and its worsening course (Cosnes, 2004) as well as for osteoporosis in some IBD patients (Silvennoinen et al., 1996) .
In the present study, sun exposure was measured indirectly, using a simple questionnaire to assess sun habits and preferences as crude estimates of sunshine exposure. The multiple regression analysis indicated that avoiding summer sunshine tended to be negatively associated with wintertime serum 25 (OH) D levels, but, somewhat surprisingly, had no significant relationship with summer-time serum 25 (OH) D levels. However, even low exposure to summer shine may dramatically improve vitamin D status, and thus classification of patients as sun-likers and avoiders may not have been sensitive enough to distinguish differences in vitamin D status during summer. For example, exposure to suberythemal doses of sunshine on hands, arms and face two or three times per week is more than adequate to satisfy vitamin D requirements (Holick, 2002) . Use of a more direct method of assessing sunshine exposure, such as UV dosimetry may be a more meaningful approach for assessing summer sunshine exposure as a determinant of serum 25 (OH) D levels (Terenetskaya, 2004) .
Small intestinal involvement was the only pathophysiologic factor found to be negatively associated with serum 25 (OH) D levels and this association was only present during winter-time. The reasons for a negative effect of small intestinal involvement on serum 25 (OH) D levels at one season and not the other are unclear, but may relate to the poorer status during winter and the increased reliance on dietary sources (which are absorbed in the small intestine) during these winter months to help maintain adequate vitamin D status. Although some studies have shown that intestinal resection (presumably leading to increased risk of malabsorption of vitamin D) negatively influenced vitamin D status (Driscoll et al., 1982; Haderslev et al., 2003) , resection was not a determinant of vitamin D status in the present study, which is in agreement with the findings of Andreassen et al. (1998) . However, in both the latter studies, the subjects had no major ileal resections and thus presumably were at less risk of malabsorption. Disease activity has also been reported to influence adversely vitamin D status in some studies (Harries et al., 1985; Tajika et al., 2004) ; however, it did not influence vitamin D status in CD patients in the present study, in agreement with the findings of Andreassen et al. (1998) . Further studies with larger sample numbers may help clarify which pathophysiologic factor are important determinants of vitamin D status in CD.
Conclusion
A high proportion (B50%) of Irish CD patients have vitamin D inadequacy (serum 25 (OH) D o50 nmol/l) during latewinter. However, low-dose vitamin D supplementation (mean B7 mg/day) was associated with a considerably lower prevalence of inadequacy/insufficiency of vitamin D in these patients. Because low-dose supplemental vitamin D was positively associated with serum 25 (OH) D levels, CD patients should be encouraged to use regular low-dose supplemental vitamin D during winter to help counteract the natural winter-time decline in serum 25 (OH) D levels. The use of vitamin D supplements may be particularly important in the case of patients who have small intestinal involvement. In addition, cessation of smoking and adequate, but responsible, exposure to summer sunlight as well as maintaining BMI in the normal range are additional factors that could help maintain adequate vitamin D levels during winter-time.
